SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 11, 2006--Hana Biosciences (AMEX:HBX - News), a biopharmaceutical company focused on advancing cancer care, received approval of its application to list its common shares on the NASDAQ National Market. Hana’s common shares will begin trading on NASDAQ on Monday, April 17, 2006 under the symbol HNAB. The trading of Hana’s shares on the American Stock Exchange will cease on the close of business on Thursday, April 13, 2006.
